Inhibition by guanidino compounds of the growth of spontaneous mammary tumours in SHN mice

Satoshi Tsunoda, Hiroshi Kawamoto, Hideo Inatomi, Kazutoshi Yamamoto, Hiroshi Nagasawa

    Research output: Contribution to journalArticle

    5 Citations (Scopus)

    Abstract

    The D-form of lombricine extracted from the earthworm was previously found to inhibit the growth of spontaneous mammary tumours of mice. In the present study, the anti-mammary tumour effects of guanidino compounds, of which structures resembled those of lombricine, i.e., guanidine-sulfate (Guanidine), 2-guanidinoethanol sulfate (2-GEt), 4-guanidino-1-butanol sulfate (4-GBt), guanidinoethylphosphate (GEP). opheline (OPHE) and the L-form of lombricine (L-Lom), were investigated in relation to their structures. In Experiment I, each guanidino compound was suspended in olive oil at the concentration of 0.3 mg/0.05 ml, and was injected subcutaneously for 10 days to SHN mice bearing spontaneous mammary tumours. 2-GEt, GEP, OPHE and L-Lom markedly inhibited mammary tumour growth, but Guanidine and 4-GBt did not. In Experiment II, the two compounds examined, 2-GEt and GEP, also significantly inhibited mammary tumour growth when given in drinking water (0.003%) for 10 days, while the effects were much weaker than those of the injected compounds. These results indicate that the existence and the length of the ethylene group are important to antitumour activity and that the site of the antitumour activity in guanidino compounds is the guanidinoethyl group. These compounds are also suggested to be more effective when administered subcutaneously rather than intragastrically.

    Original languageEnglish
    Pages (from-to)3349-3353
    Number of pages5
    JournalAnticancer Research
    Volume17
    Issue number5 A
    Publication statusPublished - 1997 Sep

    Fingerprint

    Sulfates
    Breast Neoplasms
    Guanidine
    L Forms
    Growth
    1-Butanol
    Oligochaeta
    Drinking Water
    lombricine
    2-guanidinoethanol

    Keywords

    • Guanidino compounds
    • Mammary tumour
    • Mice

    ASJC Scopus subject areas

    • Cancer Research
    • Oncology

    Cite this

    Tsunoda, S., Kawamoto, H., Inatomi, H., Yamamoto, K., & Nagasawa, H. (1997). Inhibition by guanidino compounds of the growth of spontaneous mammary tumours in SHN mice. Anticancer Research, 17(5 A), 3349-3353.

    Inhibition by guanidino compounds of the growth of spontaneous mammary tumours in SHN mice. / Tsunoda, Satoshi; Kawamoto, Hiroshi; Inatomi, Hideo; Yamamoto, Kazutoshi; Nagasawa, Hiroshi.

    In: Anticancer Research, Vol. 17, No. 5 A, 09.1997, p. 3349-3353.

    Research output: Contribution to journalArticle

    Tsunoda, S, Kawamoto, H, Inatomi, H, Yamamoto, K & Nagasawa, H 1997, 'Inhibition by guanidino compounds of the growth of spontaneous mammary tumours in SHN mice', Anticancer Research, vol. 17, no. 5 A, pp. 3349-3353.
    Tsunoda S, Kawamoto H, Inatomi H, Yamamoto K, Nagasawa H. Inhibition by guanidino compounds of the growth of spontaneous mammary tumours in SHN mice. Anticancer Research. 1997 Sep;17(5 A):3349-3353.
    Tsunoda, Satoshi ; Kawamoto, Hiroshi ; Inatomi, Hideo ; Yamamoto, Kazutoshi ; Nagasawa, Hiroshi. / Inhibition by guanidino compounds of the growth of spontaneous mammary tumours in SHN mice. In: Anticancer Research. 1997 ; Vol. 17, No. 5 A. pp. 3349-3353.
    @article{a53d6d11f7f04e719fb1de5605955861,
    title = "Inhibition by guanidino compounds of the growth of spontaneous mammary tumours in SHN mice",
    abstract = "The D-form of lombricine extracted from the earthworm was previously found to inhibit the growth of spontaneous mammary tumours of mice. In the present study, the anti-mammary tumour effects of guanidino compounds, of which structures resembled those of lombricine, i.e., guanidine-sulfate (Guanidine), 2-guanidinoethanol sulfate (2-GEt), 4-guanidino-1-butanol sulfate (4-GBt), guanidinoethylphosphate (GEP). opheline (OPHE) and the L-form of lombricine (L-Lom), were investigated in relation to their structures. In Experiment I, each guanidino compound was suspended in olive oil at the concentration of 0.3 mg/0.05 ml, and was injected subcutaneously for 10 days to SHN mice bearing spontaneous mammary tumours. 2-GEt, GEP, OPHE and L-Lom markedly inhibited mammary tumour growth, but Guanidine and 4-GBt did not. In Experiment II, the two compounds examined, 2-GEt and GEP, also significantly inhibited mammary tumour growth when given in drinking water (0.003{\%}) for 10 days, while the effects were much weaker than those of the injected compounds. These results indicate that the existence and the length of the ethylene group are important to antitumour activity and that the site of the antitumour activity in guanidino compounds is the guanidinoethyl group. These compounds are also suggested to be more effective when administered subcutaneously rather than intragastrically.",
    keywords = "Guanidino compounds, Mammary tumour, Mice",
    author = "Satoshi Tsunoda and Hiroshi Kawamoto and Hideo Inatomi and Kazutoshi Yamamoto and Hiroshi Nagasawa",
    year = "1997",
    month = "9",
    language = "English",
    volume = "17",
    pages = "3349--3353",
    journal = "Anticancer Research",
    issn = "0250-7005",
    publisher = "International Institute of Anticancer Research",
    number = "5 A",

    }

    TY - JOUR

    T1 - Inhibition by guanidino compounds of the growth of spontaneous mammary tumours in SHN mice

    AU - Tsunoda, Satoshi

    AU - Kawamoto, Hiroshi

    AU - Inatomi, Hideo

    AU - Yamamoto, Kazutoshi

    AU - Nagasawa, Hiroshi

    PY - 1997/9

    Y1 - 1997/9

    N2 - The D-form of lombricine extracted from the earthworm was previously found to inhibit the growth of spontaneous mammary tumours of mice. In the present study, the anti-mammary tumour effects of guanidino compounds, of which structures resembled those of lombricine, i.e., guanidine-sulfate (Guanidine), 2-guanidinoethanol sulfate (2-GEt), 4-guanidino-1-butanol sulfate (4-GBt), guanidinoethylphosphate (GEP). opheline (OPHE) and the L-form of lombricine (L-Lom), were investigated in relation to their structures. In Experiment I, each guanidino compound was suspended in olive oil at the concentration of 0.3 mg/0.05 ml, and was injected subcutaneously for 10 days to SHN mice bearing spontaneous mammary tumours. 2-GEt, GEP, OPHE and L-Lom markedly inhibited mammary tumour growth, but Guanidine and 4-GBt did not. In Experiment II, the two compounds examined, 2-GEt and GEP, also significantly inhibited mammary tumour growth when given in drinking water (0.003%) for 10 days, while the effects were much weaker than those of the injected compounds. These results indicate that the existence and the length of the ethylene group are important to antitumour activity and that the site of the antitumour activity in guanidino compounds is the guanidinoethyl group. These compounds are also suggested to be more effective when administered subcutaneously rather than intragastrically.

    AB - The D-form of lombricine extracted from the earthworm was previously found to inhibit the growth of spontaneous mammary tumours of mice. In the present study, the anti-mammary tumour effects of guanidino compounds, of which structures resembled those of lombricine, i.e., guanidine-sulfate (Guanidine), 2-guanidinoethanol sulfate (2-GEt), 4-guanidino-1-butanol sulfate (4-GBt), guanidinoethylphosphate (GEP). opheline (OPHE) and the L-form of lombricine (L-Lom), were investigated in relation to their structures. In Experiment I, each guanidino compound was suspended in olive oil at the concentration of 0.3 mg/0.05 ml, and was injected subcutaneously for 10 days to SHN mice bearing spontaneous mammary tumours. 2-GEt, GEP, OPHE and L-Lom markedly inhibited mammary tumour growth, but Guanidine and 4-GBt did not. In Experiment II, the two compounds examined, 2-GEt and GEP, also significantly inhibited mammary tumour growth when given in drinking water (0.003%) for 10 days, while the effects were much weaker than those of the injected compounds. These results indicate that the existence and the length of the ethylene group are important to antitumour activity and that the site of the antitumour activity in guanidino compounds is the guanidinoethyl group. These compounds are also suggested to be more effective when administered subcutaneously rather than intragastrically.

    KW - Guanidino compounds

    KW - Mammary tumour

    KW - Mice

    UR - http://www.scopus.com/inward/record.url?scp=0030785297&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0030785297&partnerID=8YFLogxK

    M3 - Article

    C2 - 9413171

    AN - SCOPUS:0030785297

    VL - 17

    SP - 3349

    EP - 3353

    JO - Anticancer Research

    JF - Anticancer Research

    SN - 0250-7005

    IS - 5 A

    ER -